The U.S. P2Y12 inhibitors market comprises drugs that block the P2Y12 receptor and inhibit platelet aggregation. These drugs are widely used to prevent blood clots in cardiovascular disorders like myocardial infarction and stroke. P2Y12 inhibitors help reduce the risk of recurrent cardiovascular events by decreasing platelet reactivity. Clopidogrel, ticagrelor, prasugrel, and cangrelor are some...